Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
The pressure is building for employers, insurers, and Medicare to pay for costly weight-loss drugs. But many health plans aren't yielding and some...
Read MoreShortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The long-running U.S. shortage of Novo Nordisk's blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than...
Read MoreEli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to...
Read More
Novo Nordisk reports positive next-generation obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday.
Read MoreEli Lilly plans at least $27 billion in new U.S. manufacturing investments
Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster...
Read MoreEnd of content
No more pages to load